Our study is the first to explore at the genetic level the possibility that cathepsin O may increase the risk of stroke in the context of AF, although the connection to cathepsin O-mediated macrophage metabolism still requires confirmation through more detailed studies. The gene discussed is CTSO; the disease is atrial fibrillation.